发明名称 |
Crotoxin Administration for Cancer Treatment |
摘要 |
A method for treating cancer using an intra-patient dose escalation procedure to deliver dosages of Crotalus durissus terrificus venom. |
申请公布号 |
US2015110770(A1) |
申请公布日期 |
2015.04.23 |
申请号 |
US201414586560 |
申请日期 |
2014.12.30 |
申请人 |
Celtic Biotech Iowa, Inc. |
发明人 |
Reid Paul F. |
分类号 |
A61K38/46;A61K35/583;A61K45/06 |
主分类号 |
A61K38/46 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating cancer comprising:
administering to a cancer patient at least one Crotalus durissus terrificus venom dosage of from about 0.04 to about 0.8 mg, the dosage being intravenously administered in an intra-patient dose escalation procedure, the intra-patient dose escalation procedure comprising consecutive administration of: about 0.04 mg/day for a 3-5 day treatment period; about 0.08 mg/day for a 3-5 day treatment period; about 0.12 mg/day for a 3-5 day treatment period; about 0.16 mg/day for a 3-5 day treatment period; about 0.2 mg/day for a 3-5 day treatment period; about 0.24 mg/day for a 3-5 day treatment period; about 0.28 mg/day for a 3-5 day treatment period; about 0.32 mg/day for a 3-5 day treatment period; about 0.36 mg/day for a 3-5 day treatment period; about 0.4 mg/day for a 3-5 day treatment period; about 0.44 mg/day for a 3-5 day treatment period; about 0.48 mg/day for a 3-5 day treatment period; about 0.52 mg/day for a 3-5 day treatment period; about 0.56 mg/day for a 3-5 day treatment period; about 0.6 mg/day for a 3-5 day treatment period; about 0.64 mg/day for a 3-5 day treatment period; about 0.68 mg/day for a 3-5 day treatment period; about 0.72 mg/day for a 3-5 day treatment period; about 0.76 mg/day for a 3-5 day treatment period; and about 0.8 mg/day for a 3-5 day treatment period; and wherein each successive dose escalation is conditioned upon the absence of dose-limiting toxicity from the previous dose. |
地址 |
West Des Moines IA US |